🇺🇸 FDA
Pipeline program

A study in healthy people to compare how 2 different high dose formulations of BI 1015550 are taken up in the body

1305-0037

Phase 1 other active

Quick answer

A study in healthy people to compare how 2 different high dose formulations of BI 1015550 are taken up in the body for Pharmacokinetic trial is a Phase 1 program (other) at Boehringer Ingelheim International GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Boehringer Ingelheim International GmbH
Indication
Pharmacokinetic trial
Phase
Phase 1
Modality
other
Status
active

Clinical trials